Clinical Trial

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

Study acronym: ProtectPrevent
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to demonstrate that a dietary supplement, which contains two strains of the probiotic L. reuteri is safe, well tolerated and able to reduce the incidence of colic and excessive crying/fussiness in healthy infants. Additionally, the study aims to investigate if children with this probiotic supplement have better stool characteristics and a more beneficial composition of the fecal and skin flora than children given a placebo during the first 3 months of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-08.
Status change: Not Yet Recruiting → Recruiting 2026-02-16
Trial Details
NCT Number NCT07347743
Lead Sponsor Universitair Ziekenhuis Brussel
Collaborators: BioGaia AB
Conditions Colic, Healthy Infants, Eczema Atopic Dermatitis
Enrollment 768 participants
Start Date 2026-01-31
Primary Completion 2028-05 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-19